CEO SUMMARY: Both companies confirm that merger talks are under way. The merger is another example of consolidation within the healthcare industry, and is expected to trigger mergers between other drug companies. Fate of SmithKlineās clinical laboratory division in the merger with Glaxo Wellcome is unclear. NEWS OF A POSSIBLE MERGER between SmithKline Beecham PLC […]
To access this post, you must purchase The Dark Report.